Biocruces Health Research Institute
Dirección de correo verificada de osakidetza.net
Citado por
Citado por
Comparison of health-related quality of life 5 years after SPIRIT: Surgical Prostatectomy Versus Interstitial Radiation Intervention Trial
JM Crook, A Gomez-Iturriaga, K Wallace, C Ma, S Fung, S Alibhai, ...
Journal of Clinical Oncology 29 (4), 362-368, 2011
Dose escalation to dominant intraprostatic lesions with MRI-transrectal ultrasound fusion High-Dose-Rate prostate brachytherapy. Prospective phase II trial
A Gomez-Iturriaga, F Casquero, A Urresola, A Ezquerro, JI Lopez, ...
Radiotherapy and Oncology 119 (1), 91-96, 2016
Metastasis-directed therapy in treating nodal oligorecurrent prostate cancer: a multi-institutional analysis comparing the outcome and toxicity of stereotactic body …
E De Bleser, BA Jereczek-Fossa, D Pasquier, T Zilli, N Van As, S Siva, ...
European urology 76 (6), 732-739, 2019
The role of re-irradiation of secondary and recurrent head and neck carcinomas. Is it a potentially curative treatment? A practical approach
J Cacicedo, A Navarro, F Alongi, AG de Iturriaga, O Del Hoyo, E Boveda, ...
Cancer treatment reviews 40 (1), 178-189, 2014
Median 5 year follow-up of 125Iodine brachytherapy as monotherapy in men aged≤ 55 years with favorable prostate cancer
AGI Piña, J Crook, J Borg, G Lockwood, N Fleshner
Urology 75 (6), 1412-1416, 2010
Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist
J Cacicedo, A Navarro, O Del Hoyo, A Gomez-Iturriaga, F Alongi, ...
The British journal of radiology 89 (1067), 20160217, 2016
A prospective analysis of factors that influence weight loss in patients undergoing radiotherapy
J Cacicedo, F Casquero, L Martinez-Indart, O Del Hoyo, AG de Iturriaga, ...
Chinese journal of cancer 33 (4), 204, 2014
Incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: multicenter prospective observational study
A Gomez-Iturriaga, J Cacicedo, A Navarro, V Morillo, P Willisch, ...
BMC Palliative Care 14 (1), 1-7, 2015
Biochemical disease-free rate and toxicity for men treated with iodine-125 prostate brachytherapy with D90≥ 180 Gy
AGI Piña, J Crook, J Borg, C Ma
International Journal of Radiation Oncology* Biology* Physics 78 (2), 422-427, 2010
Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent …
M Moreno-Jiménez, J Aristu, JM López-Picazo, LI Ramos, A Gúrpide, ...
Radiotherapy and Oncology 88 (3), 342-350, 2008
Phase I–II trial of perioperative high-dose-rate brachytherapy in oral cavity and oropharyngeal cancer
R Martínez-Monge, A Gómez-Iturriaga, M Cambeiro, C Garrán, ...
Brachytherapy 8 (1), 26-33, 2009
PEACE V–salvage treatment of oligorecurrent nodal prostate cancer metastases (STORM): a study protocol for a randomized controlled phase II trial
A De Bruycker, A Spiessens, P Dirix, N Koutsouvelis, I Semac, ...
BMC cancer 20 (1), 1-12, 2020
Oligometastatic prostate cancer: the game is afoot
A Lancia, T Zilli, V Achard, P Dirix, W Everaerts, A Gomez-Iturriaga, ...
Cancer treatment reviews 73, 84-90, 2019
Is argon plasma coagulation an effective and safe treatment option for patients with chronic radiation proctitis after high doses of radiotherapy
E Hortelano, A Gómez-Iturriaga, R Ortiz-de-Zárate, M Zaballa, Á Barturen, ...
Rev Esp Enferm Dig 106 (3), 165-170, 2014
The efficacy of hyperbaric oxygen therapy in the treatment of medically refractory soft tissue necrosis after penile brachytherapy
A Gomez-Iturriaga, J Crook, W Evans, EP Saibishkumar, J Jezioranski
Brachytherapy 10 (6), 491-497, 2011
Early breast cancer treated with conservative surgery, adjuvant chemotherapy, and delayed accelerated partial breast irradiation with high-dose-rate brachytherapy
A Gómez-Iturriaga, L Pina, M Cambeiro, F Martínez-Regueira, ...
Brachytherapy 7 (4), 310-315, 2008
Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma
J Cacicedo, I Fernandez, O Del Hoyo, A Navarro, A Gomez-Iturriaga, ...
Clinical and Translational Oncology 19 (11), 1337-1349, 2017
Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance
JL Torrecilla, A Hervás, A Zapatero, AG Caamaño, V Macías, I Herruzo, ...
Reports of Practical Oncology and Radiotherapy 20 (4), 259-272, 2015
Health-related-quality-of-life and toxicity after single fraction 19 Gy high-dose-rate prostate brachytherapy: Phase II trial
A Gomez-Iturriaga, F Casquero, JI Pijoan, P Minguez, JM Espinosa, ...
Radiotherapy and Oncology 126 (2), 278-282, 2018
Radium-223 within the evolving treatment options for metastatic castration-resistant prostate cancer: recommendations from a European Expert Working Group
JM O'Sullivan, J Carles, R Cathomas, A Gomez-Iturriaga, D Heinrich, ...
European urology oncology 3 (4), 455-463, 2020
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20